08.19.15
Kowa Company Ltd., a Japanese pharmaceutical company with affiliates in North America, Asia and Europe, has migrated to Oracle Argus Cloud Service Global and Oracle Argus Cloud Japan. The company says as it sets out to execute an aggressive international growth plan, Oracle Argus Cloud Service Global and Oracle Argus Cloud Japan will help it manage compliance with the increasingly complex regulatory requirements and reduce its overall pharmacovigilance IT spend.
Oracle Health Sciences Consulting assisted in the migration, leveraging reusable assets built from past engagements, and from the experience of their global, multilingual and multicultural team members.
Kowa is taking advantage of Oracle Argus Cloud Service’s capabilities to support compliance with regulatory requirements in Japan, North and Europe and expects to be better prepared to address international and emerging compliance reporting requirements, such as E2B (R3). By using Oracle Argus Cloud Service to consolidate its safety infrastructure into a single, scalable, global database, Kowa can also continue to reduce its IT complexity and maintenance requirements while establishing the pharmaconvigilance system needed for its business expansion into new markets.
“As we continue to expand our company and products globally, we need a safety platform that supports our global pharmacovigilance user base with the highest standards of compliance reporting, reliability and performance in the countries where we are marketing the products,” said Kazuhiro Aizawa, director of pharmacovigilance, Kowa. “Oracle Argus Cloud Service has helped us to meet this goal, while enabling us to reduce our total cost of ownership.”
“The networked, global nature of the life sciences industry has made safety reporting more complex than ever,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “Oracle Argus Cloud Service helps life sciences organizations across the spectrum reduce risk and cut total cost of IT ownership, while offering outstanding security, scalability and performance.”
Oracle Health Sciences Consulting assisted in the migration, leveraging reusable assets built from past engagements, and from the experience of their global, multilingual and multicultural team members.
Kowa is taking advantage of Oracle Argus Cloud Service’s capabilities to support compliance with regulatory requirements in Japan, North and Europe and expects to be better prepared to address international and emerging compliance reporting requirements, such as E2B (R3). By using Oracle Argus Cloud Service to consolidate its safety infrastructure into a single, scalable, global database, Kowa can also continue to reduce its IT complexity and maintenance requirements while establishing the pharmaconvigilance system needed for its business expansion into new markets.
“As we continue to expand our company and products globally, we need a safety platform that supports our global pharmacovigilance user base with the highest standards of compliance reporting, reliability and performance in the countries where we are marketing the products,” said Kazuhiro Aizawa, director of pharmacovigilance, Kowa. “Oracle Argus Cloud Service has helped us to meet this goal, while enabling us to reduce our total cost of ownership.”
“The networked, global nature of the life sciences industry has made safety reporting more complex than ever,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences. “Oracle Argus Cloud Service helps life sciences organizations across the spectrum reduce risk and cut total cost of IT ownership, while offering outstanding security, scalability and performance.”
